drugset / Trial / NCT02362711

Efficacy and Safety, Long-Term Study of NPC-16 to Treat Dysmenorrhea

NCT02362711

Phase 3 Completed 248 enrolled Nobelpharma
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this long-term study is to determine whether NPC-16 is effective in the treatment of dysmenorrhea.

Timeline

Start
2015-02
Primary completion
2017-01
Completion
2017-01-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Levonorgestrel Small molecule 0.09 mg
Subject ethinyl estradiol Small molecule 0.02 mg

Indications